# Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects

> **NCT01099683** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 26 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DRUG:** NRL001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01099683
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099683, "Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01099683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*